Related Experiment Videos
Comparative study of pirlindole, a selective RIMA, and its two enantiomers using biochemical and behavioural
J Bruhwyler1, J F Liégeois, J Gérardy
1Therabel Research s.a., Brussels, Belgium.
Behavioural Pharmacology
|January 16, 1999
Summary
This study compared racemic pirlindole and its enantiomers for monoamine oxidase A (MAO-A) inhibition. The S-(+) enantiomer showed slightly greater potency, consistent across biochemical and behavioral antidepressant models.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Monoamine oxidase A (MAO-A) and B interactions are stereospecific.
- Pirlindole is a selective and reversible MAO-A inhibitor.
Purpose of the Study:
- To compare the biochemical and behavioral effects of racemic pirlindole and its individual enantiomers.
- To investigate the role of absolute configuration in MAO-A inhibition and antidepressant activity.
Main Methods:
- In vitro and ex vivo determination of rat brain MAO-A and MAO-B activity.
- Behavioral models including the forced swimming test and reserpine-induced hypothermia and ptosis test.
Main Results:
- In vitro MAO-A IC50 values were 0.24, 0.43, and 0.18 microM for racemic, R-(-)-, and S-(+)-pirlindole, respectively.
- Ex vivo ID50 values were 24.4, 37.8, and 18.7 mg/kg i.p. for the respective compounds.
- All compounds exhibited an antidepressant profile in behavioral tests, with ratios between enantiomers around 2.0.
Conclusions:
- The S-(+) enantiomer of pirlindole demonstrated slightly higher in vitro and ex vivo potency against MAO-A.
- Stereochemistry influences pirlindole's interaction with MAO-A, reflected in both biochemical and behavioral outcomes.
- Pirlindole enantiomers possess antidepressant properties, supporting further investigation into stereospecific drug design.